High prevalence of PER-1 extended-spectrum β-lactamase-producing Acinetobacter spp. in Korea

Antimicrobial Agents and Chemotherapy

Volumn 47, Issue 5, 2003, Pages 1749-1751

  Yong, Dongeun ^a   Shin, Jong Hee ^b   Kim, Sinyoung ^a   Lim, Youngsik ^a   Yum, Jong Hwa ^a   Lee, Kyungwon ^a   Chong, Yunsop ^a   Bauernfeind, Adolf ^c  

^a Yonsei University College of Medicine   (South Korea)

^b Chonnam National University Medical School   (South Korea)

^c MICOER Institute   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AZTREONAM; BACTERIAL PROTEIN; BETA LACTAMASE; CEFEPIME; CEFOTAXIME; COTRIMOXAZOLE; PROTEIN PER 1; SULTAMICILLIN; TETRACYCLINE; UNCLASSIFIED DRUG;

ACINETOBACTER; ANTIBIOTIC SENSITIVITY; ARTICLE; ASIA; CRITICAL ILLNESS; EUROPE; INTENSIVE CARE UNIT; KOREA; MOLECULAR CLONING; NONHUMAN; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS; SPUTUM;

ACINETOBACTER; BETA-LACTAMASES; DRUG RESISTANCE, BACTERIAL; ELECTROPHORESIS, GEL, PULSED-FIELD; KOREA; PSEUDOMONAS AERUGINOSA;

EID: 0038334864     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.47.5.1749-1751.2003     Document Type: Article

References (13)

1. PER-2, which encodes an extended-spectrum class A β-lactamase. Antimicrob. Agents Chemother. 40:616-620.
2. Chong. Y., K. Lee, and O. H. Kwon. 1993. In-vitro activities of cefepime against Enterobacter cloacae, Serratia marcescens, Pseudomonas aeruginosa and other aerobic gram-negative bacilli. J. Antimicrob. Chemother. 32 (Suppl. B):21-29.
3. Kiska, D. L., and P. H. Gilligan. 1999. Pseudomonas, p. 517-525. In P. R. Murray, E. J. Baron, M. A. Pfaller, F. C. Tenover, and R. H. Yolken (ed.), Manual of clinical microbiology, 7th ed. American Society for Microbiology, Washington, D.C.
4. VIM-2 cassette-containing novel integrons in metallo-β-lactamase-producing Pseudomonas aeruginosa and Pseudomonas putida isolates disseminated in a Korean hospital. Antimicrob. Agents Chemother. 46:1053-1058.
5. Luzzaro, F., E. Mantengoli, M. Perilli, G. Lombardi, V. Orlandi, A. Orsatti, G. Amicosante, G. M. Rossolini, and A. Toniolo. 2001. Dynamics of a nosocomial outbreak of multidrug-resistant Pseudomonas aeruginosa producing the PER-1 extended-spectrum β-lactamase. J. Clin. Microbiol. 39:1865-1870.
6. National Committee for Clinical Laboratory Standards. 1999. Performance standards for antimicrobial susceptibility testing. Ninth information supplement, M100-S9. National Committee for Clinical Laboratory Standards, Wayne, Pa.
7. Nordmann, P., E. Ronco, T. Naas, C. Duport, Y. Michel-Briand, and R. Labia. 1993. Characterization of a novel extended-spectrum β-lactamase from Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 37:962-969.
8. Nordmann, P., and T. Naas. 1994. Sequence analysis of PER-1 extended-spectrum β-lactamase from Pseudomonas aeruginosa and comparison with class A β-lactamases. Antimicrob. Agents Chemother. 38:104-114.
9. Poirel, L., A. Karim, A. Mercat, I. Le Thomas, H. Vahaboglu, C. Richard, and P. Nordmann. 1999. Extended-spectrum β-lactamase-producing strain of Acinetobacter baumannii isolated from a patient in France. J. Antimicrob. Chemother. 43:157-158.
10. Schrechenberger, P. C., and A. Graevenitz. 1999. Acinetobacter, Achromobacter, Alcaligenes, Moraxella, Methylobacterium, and other nonfermentative gram-negative rods, p. 539-560. In P. R. Murray, E. J. Baron, M. A. Pfaller, F. C. Tenover, and R. H. Yolken (ed.), Manual of clinical microbiology, 7th ed. American Society for Microbiology, Washington, D.C.
11. Vahaboglu, H., L. M. Hall, L. Mulazimoglu, S. Dodanli, I. Yildirim, and D. M. Livermore. 1995. Resistance to extended-spectrum cephalosporins, caused by PER-1 β-lactamase, in Salmonella typhimurium from Istanbul, Turkey. J. Med. Microbiol. 43:294-299.
12. Vahaboglu, H., R. Ozturk, G. Aygun, F. Coskunkan, A. Yaman, A. Kaygusuz, H. Leblebicioglu, I. Balik, K. Aydin, and M. Otkun. 1997. Widespread detection of PER-1-type extended-spectrum β-lactamases among nosocomial Acinetobacter and Pseudomonas aeruginosa isolates in Turkey: a nationwide multicenter study. Antimicrob. Agents Chemother. 41:2265-2269.
13. Vahaboglu, H., F. Coskunkan, O. Tansel, R. Ozturk, N. Sahin, I. Koksal, B. Kocazeybek, M. Tatman-Otkun, H. Leblebicioglu, M. A. Ozinel, H. Akalin, S. Kocagoz, and V. Korten. 2001. Clinical importance of extended-spectrum β-lactamase (PER-1-type)-producing Acinetobacter spp. and Pseudomonas aeruginosa strains. J. Med. Microbiol. 50:642-645.